Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-12-01FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc. The action reflects approved product changes und…
-
FDA approval · 2016-11-22FDA Approved: NEXTERONE — Supplemental Application (Baxter Healthcare Company)
The FDA approved a supplemental application for Nexterone (amiodarone hydrochloride) submitted by Baxter Healthcare Company.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved a supplemental application for verapamil hydrochloride from Wilshire Pharmaceuticals, Inc., updating the existing NDA.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals Inc)
FDA approved a supplemental application for Verapamil hydrochloride from Teva Pharmaceuticals Inc.
-
FDA approval · 2016-11-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (EXELA PHARMA SCIENCES, LLC)
The FDA approved a supplemental application for verapamil hydrochloride from Exela Pharma Sciences, LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for diltiazem hydrochloride. The approval confirms a modification to the pr…
-
FDA approval · 2016-11-18FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2016-11-08FDA Approved: MATZIM LA — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for MATZIM LA, a diltiazem hydrochloride product from Actavis Pharma, Inc.
-
FDA approval · 2016-10-21FDA Approved: SOTALOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved an original ANDA for sotalol hydrochloride (Sotalol) from Unichem Pharmaceuticals (USA), Inc., enabling generic access to this …
-
FDA approval · 2016-06-06FDA Approved: DOFETILIDE — Original Application (Dr. Reddy's Labratories Inc.)
FDA approved Dr. Reddy's Laboratories' original application for dofetilide, enabling a generic version of the antiarrhythmic. It is indicate…
-
FDA approval · 2016-05-29FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application for Propafenone hydrochloride from Strides Pharma Science Limited.
-
FDA approval · 2016-05-11FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for propafenone hydrochloride (generic) manufactured by Aurobindo Pharma Limited.
-
FDA approval · 2016-05-10FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)
The FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) filed by Legacy Pharma USA, Inc.
-
FDA approval · 2016-04-07FDA Approved: ESMOLOL HYDROCHLORIDE IN WATER — Original Application (WG Critical Care, LLC)
FDA approved Esmolol hydrochloride in water as a new drug product under NDA205703 (Original Application) from WG Critical Care, LLC.
-
FDA approval · 2016-03-08FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for TIKOSYN (dofetilide) from Pfizer Laboratories Div Pfizer Inc.
-
FDA approval · 2016-02-12FDA Approved: MULTAQ — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for MULTAQ (dronedarone) submitted by Sanofi-Aventis U.S. LLC. The document describes the agency…
-
FDA approval · 2016-01-10FDA Approved: DIGOXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Digoxin from Hikma Pharmaceuticals USA Inc., indicating a supplemental approval (AP) for the pro…
-
FDA approval · 2015-11-25FDA Approved: TIKOSYN — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Tikosyn (dofetilide) from Pfizer Laboratories Div Pfizer Inc. The action represents a supplement…
-
FDA approval · 2015-11-20FDA Approved: DILTIAZEM HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved a supplemental application for diltiazem hydrochloride extended-release from Oceanside Pharmaceuticals.
-
FDA approval · 2015-10-26FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for verapamil hydrochloride (Actavis Pharma, Inc.), a generic product.
-
FDA approval · 2015-10-26FDA Approved: XARELTO — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for XARELTO (rivaroxaban) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2015-10-14FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Verapamil Hydrochloride (generic) from Chartwell RX, LLC.
-
FDA approval · 2015-10-05FDA Approved: AMIODARONE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for amiodarone hydrochloride submitted by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2015-09-03FDA Approved: LANOXIN — Supplemental Application (Advanz Pharma (US) Corp.)
The FDA approved a supplemental application for Lanoxin (digoxin) from Advanz Pharma US Corp., associated with NDA 020405. The supplement ma…
-
FDA approval · 2015-08-27FDA Approved: PROPAFENONE HYDROCHLORIDE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved Strides Pharma Science Limited's supplemental application for propafenone hydrochloride, enabling a generic version of this…